Concentration-dependent block of sodium current in guinea pig ventricular myocytes by a class III antiarrhythmic agent, MS-551

Journal of Cardiovascular Pharmacology

Volumn 32, Issue 5, 1998, Pages 819-825

  Suzuki, Kazuyuki ^a   Furukawa, Taiji ^a   Koyama, Yutaka ^a   Sagawa, Toshio ^a   Nishimura, Masao ^a   Yamanaka, Masami ^a  

^a TEIKYO UNIVERSITY   (Japan)

Author keywords

Antiarrhythmic agent; MS 551; Sodium channel

Indexed keywords

ANTIARRHYTHMIC AGENT; NIFEKALANT; SODIUM CHANNEL;

ANIMAL CELL; ANTIARRHYTHMIC ACTIVITY; ARTICLE; GUINEA PIG; HEART ARRHYTHMIA; HEART MUSCLE CELL; NONHUMAN; PRIORITY JOURNAL; SODIUM CURRENT;

ANIMALS; ANTI-ARRHYTHMIA AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GUINEA PIGS; HEART; PYRIMIDINONES; SODIUM CHANNEL BLOCKERS;

EID: 0031734237     PISSN: 01602446     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005344-199811000-00019     Document Type: Article

References (31)

1. Burkart F, Pfisterer M, Kiowski W, et al. Effect of antiarrhythmic therapy on mortality in survivors of myocardial infarction with asymptomatic complex ventricular arrhythmias: basal Antiarrhythmic Study of Infarct Survival (BASIS). J Am Coll Cardiol 1990;16:1711-8.
2. Doval H, Nul D, Grancelli H, et al. Randomized trial of low-dose amiodarone in severe congestive heart failure. Lancet 1994;344:493-8.
3. Mason J. A comparison of seven antiarrhythmic drugs in patients with ventricular tachyarrhythmias. N Engl J Med 1993;329:452-8.
4. Vaughan Williams E. A classification of anti-arrhythmic actions reassessed after a decade of new drugs. J Clin Pharmacol 1984;24:129-47.
5. Task Force of the Working Group on Arrhythmias of the European Society of Cardiology. The Sicilian Gambit; a new approach to the classification of antiarrhythmic drugs based on their action on arrhythmogenic mechanisms. Circulation 1991;84:1831.
6. Hashimoto K, Ishii M, Kamiya J. Cellular electrophysiological effect of MS-551, a new class III, antiarrhythmic agent, in various cardiac tissues: comparison with d-sotalol. Eur J Pharmacol 1990;183:1164.
7. + channel blockers and activators in cardiac arrhythmias. Cardiovasc Drug Rev 1989;7:199-209.
8. Saeki T, Nishimura M, Follmer CH, Watanabe Y. Selective block of delayed rectifying potassium current in the rabbit sinoatrial node by a novel class III antiarrhythmic agent MS-551. Heart Vessels 1994;9:87-95.
9. Sato R, Koumi SI, Hisatome I, et al. A new class III antiarrhythmic drug, MS-551, blocks the inward rectifier potassium channel in isolated guinea pig ventricular myocytes. J Pharmacol Exp Ther 1995;274:469-74.
10. Martin DK, Nakaya Y, Wyse KR, Bursill JA, West PD, Campbell TJ. Inhibition of ATP-sensitive potassium channels in cardiac myocytes by the novel class III antiarrhythmic agent MS-551. Pharmacol Toxicol 1995;77:65-70.
11. Nakaya H, Tohse N, Takeda Y, Kanno M. Effects of MS-551, a new class III antiarrhythmic drug, on action potential and membrane currents in rabbit ventricular myocytes. Br J Pharmacol 1993;109:157-63.
12. Furukawa T, Koumi S, Sakakibara Y, et al. An analysis of lidocaine block of sodium current in isolated human atrial and ventricular myocytes. J Mol Cell Cardiol 1995;27:831-46.
13. Ogata N, Nishimura M, Narahashi T. Kinetics of chlorpromazine block of sodium channel in single guinea pig cardiac myocytes. J Pharmacol Exp Ther 1988;248:605-13.
14. Hondeghem L, Katzung B. Antiarrhythmic agents: the modulated receptor mechanism of action of sodium and calcium channel-blocking drugs. Annu Rev Pharmacol Toxicol 1984;24:387-427.
15. Hamill OP, Marty E, Neher B, Sakmann B, Sigworth FJ. Improved patch-clamp techniques for high-resolution current recording from cells and cell-free membrane patches. Pflugers Arch 1981;391:85-100.
16. Bezanilla F, Armstrong C. Inactivation of sodium channels. I. Sodium current experiments. J Gen Physiol 1979;70:594-66.
17. Fernandez J, Fox A, Krasne S. Membrane patches and whole-cell membranes: a comparison of electrical properties in rat clonal pituitary (GH3) cells. J Physiol (Lond) 1984;356:565-85.
18. Marquardt D. An algorithm for least-squares estimation of non-linear parameters. J Soc Ind Appl Math 1963;11:431-41.
19. Gilliam F, Starmer C, Grant A. Blockade of rabbit atrial sodium channels by lidocaine: characterization of continuous and frequency-dependent blocking. Circ Res 1989;65:723-39.
20. Bells B, Hescheler J, Trube G. Changes of membrane currents in cardiac cells induced by long whole-cell recordings and tolbutamide. Pflugers Arch 1987;397:582-8.
21. Follmer C, Ten Eick R, Yeh J. Sodium current kinetics in cat atrial myocytes. J Physiol (Lond) 1987;384:169-97.
22. Jia H, Furukawa T, Singer DH, et al. Characteristics of lidocaine block of sodium channels in single human atrial cells. J Pharmacol Exp Ther 1992;264:1275-84.
23. Bean BP, Cohen CJ, W. TR. Lidocaine block of cardiac sodium channels. J Gen Physiol 1983;81:613-42.
24. Follmer CH, Aomine M, Yeh JZ, Singer DH. Amiodarone-induced block of sodium current in isolated cardiac cells. J Pharmacol Exp Ther 1987;243:187-93.
25. Hondeghem LM, Katzung BG. Time- and voltage-dependent interactions of antiarrhythmic drugs with cardiac sodium channels. Biochim Biophys Acta 1977;472:373-98.
26. Starmer CF, Grant AO, Strauss HC. Mechanism of use-dependent block of sodium channels in excitable membranes by local anesthetics. Biophys J 1984;46:15-27.
27. Starmer CF, Grant AO. Phasic ion channel blockade: a kinetic model and parameter estimation procedure. Mol Pharmacol 1985;28:348-56.
28. Ogata N, Narahashi T. Block of sodium channels by psychotropic drugs in single guinea pis cardiac myocytes. Br J Pharmacol 1989;97:905-13.
29. + channel kinetics in cell-attached patch recordings. Am J Physiol 1990;258:H247-54.
30. Makielski JC, Sheets MF, Hanck DA, January CT, Fozzard HA. Sodium current in voltage clamped internally perfused canine cardiac Purkinje cells. Biophys J 1987;52:1-11.
31. Sanchez-Chapula J, Tsuda Y, Josephson I. Voltage- and use-dependent effects of lidocaine on sodium current in rat single ventricular cells. Circ Res 1983;52:557-65.